Why this grouping
MONDO alignment & provenance
IUIS Table 1 aligns closely with MONDO combined immunodeficiency (MONDO:0015131), but MONDO does not nest that class under inborn error of immunity (MONDO:0003778) — both are immune-system-disorder siblings. broadMatch because this is an IUIS-guided partial union: Activated PI3K-delta syndrome is classified under IUIS combined immunodeficiency but sits outside MONDO:0015131's is-a subtree. See `grouping_mondo_gaps.py --audit`.
MONDO consistency: consistent 2/3 listed members are is-a descendants of MONDO:0015131. Activated PI3K-delta syndrome is an IUIS Table 1 member, but MONDO:0018338 lies outside this subtree; this discrepancy is recorded rather than used to determine IUIS-table membership.
Membership criteria
- HAS CLASSIFICATION
Assigned to IUIS Table 1 (combined immunodeficiency) on the member Disease entry via classifications.iuis_category. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block rather than a free-text `parents:`/`categories:` tag that happens to use the same words.
Coverage and gaps
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Assigned to IUIS Table 1 (combined immunodeficiency) on the member Disease entry via classifications.iuis_category. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block rather than a free-text `parents:`/`categories:` tag that happens to use the same words. |
|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
Activated PI3K-delta syndrome
DISEASE
Differentiating mechanismHeterozygous gain-of-function PIK3CD or PIK3R1 variants hyperactivate PI3K-delta-AKT-mTOR signaling, causing lymphoproliferation, bronchiectasis, and herpesvirus susceptibility with immune dysregulation (APDS).
PIK3CD hgnc:8977
|
Activated PI3K-delta syndrome
MONDO:0018338
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Cernunnos-XLF deficiency
DISEASE
Differentiating mechanismBiallelic NHEJ1 (Cernunnos/XLF) deficiency impairs nonhomologous end-joining, causing microcephaly, growth retardation, and combined T-/B-cell immunodeficiency with radiosensitivity.
NHEJ1 hgnc:25737
|
Cernunnos-XLF deficiency
MONDO:0012650
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
STK4 Deficiency
DISEASE
Differentiating mechanismBiallelic STK4 (MST1) loss impairs naive T-cell survival via FOXO1 and IL-7R/BCL2, with defective lymphocyte adhesion and chemotaxis; combined T- and B-cell lymphopenia with autoimmunity and EBV-driven lymphoproliferation.
STK4 hgnc:11408
|
STK4 deficiency
MONDO:0013934
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Immunodeficiency 131
DISEASE
Differentiating mechanismA recurrent heterozygous IRF4 p.Thr95Arg substitution in the DNA-binding domain acts simultaneously as hypomorph, hypermorph and neomorph (multimorphic), altering IRF4's DNA-binding specificity rather than merely reducing its output. The result is agammaglobulinemia with impaired B-cell maturation and class switching plus reduced TH17/TFH populations, and susceptibility to Pneumocystis jirovecii pneumonia — an autosomal dominant combined immunodeficiency, and one of the seven Table 1 entities newly recognized in the IUIS 2024 update.
IRF4 hgnc:6119
|
immunodeficiency 131
MONDO:0976229
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Severe Combined Immunodeficiency
DISEASE
Differentiating mechanismThe severe end of IUIS Table 1: profound failure of T-lymphocyte development that abrogates adaptive immunity from birth, reached by three mechanistically distinct routes — defective common-gamma-chain cytokine receptor signaling (IL2RG, JAK3, IL7R), failed V(D)J recombination or DNA double-strand-break repair (RAG1, RAG2, DCLRE1C/Artemis), and purine-salvage metabolite toxicity (ADA). Unlike the gene-specific Table 1 members alongside it, this entry is curated as the SCID concept itself, with the causal genes carried as subtypes.
IL2RG hgnc:6010
|
severe combined immunodeficiency
MONDO:0015974
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Combined Immunodeficiencies IEIs
display_name: Combined Immunodeficiencies IEIs (IUIS Table 1)
creation_date: "2026-06-13T00:00:00Z"
description: >-
IUIS Table 1 — immunodeficiencies affecting both cellular and humoral
immunity. These combined immunodeficiencies (CID) and severe combined
immunodeficiencies (SCID) feature impaired T-cell development or function
with secondary B-cell/antibody defects, predisposing to early-onset
opportunistic and bacterial infections.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PHENOTYPE
grouping_rationale: >-
Grouped on the IUIS Table 1 combined cellular-and-humoral immunodeficiency
phenotype. Members differ in the causal gene and whether T-cell deficiency
is severe (SCID-equivalent) or moderate (CID). Kept as separate Disease
entries because gene, inheritance, and syndromic features differ. Syndromic
forms with prominent non-immune features are grouped under the sibling
Combined Immunodeficiency with Syndromic Features IEIs grouping.
mappings:
mondo_mappings:
- term:
id: MONDO:0015131
label: combined immunodeficiency
mapping_predicate: skos:broadMatch
mapping_source: MONDO
mapping_justification: >-
IUIS Table 1 aligns closely with MONDO combined immunodeficiency
(MONDO:0015131), but MONDO does not nest that class under inborn error
of immunity (MONDO:0003778) — both are immune-system-disorder siblings.
broadMatch because this is an IUIS-guided partial union: Activated
PI3K-delta syndrome is classified under IUIS combined immunodeficiency
but sits outside MONDO:0015131's is-a subtree. See
`grouping_mondo_gaps.py --audit`.
consistency:
- reference: MONDO
consistent: CONSISTENT
notes: >-
2/3 listed members are is-a descendants of MONDO:0015131. Activated
PI3K-delta syndrome is an IUIS Table 1 member, but MONDO:0018338
lies outside this subtree; this discrepancy is recorded rather than
used to determine IUIS-table membership.
membership_criteria:
- description: >-
A disorder belongs to IUIS Table 1 if it is an IEI with combined cellular
and humoral immunodeficiency without syndromic features being the primary
organizing axis.
criteria_semantics: NECESSARY
logic:
criterion_predicate: HAS_CLASSIFICATION
classification: "iuis_category:combined immunodeficiency"
description: >-
Assigned to IUIS Table 1 (combined immunodeficiency) on the member
Disease entry via classifications.iuis_category. Stated in the keyed
`<slot>:<value>` form so the audit reads the structured
classifications block rather than a free-text `parents:`/`categories:`
tag that happens to use the same words.
members:
- member: STK4 Deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic STK4 (MST1) loss impairs naive T-cell survival via FOXO1 and
IL-7R/BCL2, with defective lymphocyte adhesion and chemotaxis; combined
T- and B-cell lymphopenia with autoimmunity and EBV-driven
lymphoproliferation.
gene:
preferred_term: STK4
term:
id: hgnc:11408
label: STK4
- member: Cernunnos-XLF deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic NHEJ1 (Cernunnos/XLF) deficiency impairs nonhomologous
end-joining, causing microcephaly, growth retardation, and combined
T-/B-cell immunodeficiency with radiosensitivity.
gene:
preferred_term: NHEJ1
term:
id: hgnc:25737
label: NHEJ1
- member: Activated PI3K-delta syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Heterozygous gain-of-function PIK3CD or PIK3R1 variants hyperactivate
PI3K-delta-AKT-mTOR signaling, causing lymphoproliferation,
bronchiectasis, and herpesvirus susceptibility with immune dysregulation
(APDS).
gene:
preferred_term: PIK3CD
term:
id: hgnc:8977
label: PIK3CD
- member: Severe Combined Immunodeficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
The severe end of IUIS Table 1: profound failure of T-lymphocyte
development that abrogates adaptive immunity from birth, reached by
three mechanistically distinct routes — defective common-gamma-chain
cytokine receptor signaling (IL2RG, JAK3, IL7R), failed V(D)J
recombination or DNA double-strand-break repair (RAG1, RAG2,
DCLRE1C/Artemis), and purine-salvage metabolite toxicity (ADA). Unlike
the gene-specific Table 1 members alongside it, this entry is curated as
the SCID concept itself, with the causal genes carried as subtypes.
gene:
preferred_term: IL2RG
term:
id: hgnc:6010
label: IL2RG
- member: Immunodeficiency 131
member_type: DISEASE
differentiating_mechanisms:
- description: >-
A recurrent heterozygous IRF4 p.Thr95Arg substitution in the DNA-binding
domain acts simultaneously as hypomorph, hypermorph and neomorph
(multimorphic), altering IRF4's DNA-binding specificity rather than
merely reducing its output. The result is agammaglobulinemia with
impaired B-cell maturation and class switching plus reduced TH17/TFH
populations, and susceptibility to Pneumocystis jirovecii pneumonia —
an autosomal dominant combined immunodeficiency, and one of the seven
Table 1 entities newly recognized in the IUIS 2024 update.
gene:
preferred_term: IRF4
term:
id: hgnc:6119
label: IRF4
notes: >-
Expanded 2026-08-20 with Severe Combined Immunodeficiency and Immunodeficiency
131 (IRF4), both of which already carried
`classifications.iuis_category: combined immunodeficiency` but were not listed
here. Note the two member shapes now sitting side by side: three gene-specific
entities (STK4, NHEJ1, PIK3CD/PIK3R1) and one concept-level entity (SCID)
whose causal genes are carried as `has_subtypes` rather than as separate
Disease entries. IUIS Table 1 enumerates 73 mutant genes, so neither shape is
wrong, but a consumer counting members of this grouping is not counting IUIS
entities.